Beacon Biosignals, Inc. announced it raised $29.9 Million in an initial filing from an offering of $29.9 Million

Company

Location

About

Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.